Overview

Pharmacological Intervention in Diabetic Retinopathy

Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if diabetic retinopathy can be treated with prostaglandin analogues, prostaglandin synthesis inhibitors or carbonic anhydrases inhibitors.
Phase:
N/A
Details
Lead Sponsor:
University of Aarhus
Treatments:
Diclofenac
Dorzolamide
Latanoprost
Ophthalmic Solutions
Tetrahydrozoline